Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the impact of 12 weeks of exercise on cognition in patients with end stage renal disease.
Patients with end stage renal disease have higher cognitive impairment than general population. They also have decreased physical and functional capacity. Exercise has shown to improve cognition in general population. This study will evaluate if exercise improves cognition in dialysis patients. It will also evaluate whether exercise affects performance in daily activities, mood or depression and inflammatory markers in the blood.
Age
20 - No limit years
Sex
ALL
Healthy Volunteers
No
University of Kansas Medical Center
Kansas City, Kansas, United States
Start Date
May 1, 2014
Primary Completion Date
December 1, 2017
Completion Date
December 1, 2017
Last Updated
March 29, 2019
20
ACTUAL participants
Aerobic Exercise
OTHER
Standard Care Dialysis
PROCEDURE
Lead Sponsor
University of Kansas Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06154174